Header Logo

Connection

EUGENIE S KLEINERMAN to Mice, Nude

Back to Details
This is a "connection" page, showing publications EUGENIE S KLEINERMAN has written about Mice, Nude.
EUGENIE S KLEINERMAN
Connection Strength
1.785
Mice, Nude
  1. Exercise intervention decreases acute and late doxorubicin-induced cardiotoxicity. Cancer Med. 2021 11; 10(21):7572-7584.
    View in: PubMed
    Score: 0.116
  2. miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating FAS Promoter Activity and Can be Therapeutically Targeted to Inhibit Lung Metastases. Mol Cancer Ther. 2018 01; 17(1):130-139.
    View in: PubMed
    Score: 0.088
  3. Aerosol interleukin-2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis. Pediatr Blood Cancer. 2014 Aug; 61(8):1362-8.
    View in: PubMed
    Score: 0.069
  4. Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis. Pediatr Blood Cancer. 2014 Apr; 61(4):618-26.
    View in: PubMed
    Score: 0.067
  5. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases. Curr Cancer Drug Targets. 2013 May; 13(4):411-22.
    View in: PubMed
    Score: 0.065
  6. Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts. Pediatr Blood Cancer. 2013 Apr; 60(4):575-9.
    View in: PubMed
    Score: 0.063
  7. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res. 2012 Feb 15; 72(4):908-16.
    View in: PubMed
    Score: 0.059
  8. Genetically modified T cells targeting interleukin-11 receptor a-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases. Cancer Res. 2012 Jan 01; 72(1):271-81.
    View in: PubMed
    Score: 0.058
  9. CAPER-a alternative splicing regulates the expression of vascular endothelial growth factor165 in Ewing sarcoma cells. Cancer. 2012 Apr 15; 118(8):2106-16.
    View in: PubMed
    Score: 0.058
  10. Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases. Cancer. 2011 Aug 01; 117(15):3457-67.
    View in: PubMed
    Score: 0.055
  11. Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung. Angiogenesis. 2011 May; 14(2):125-33.
    View in: PubMed
    Score: 0.055
  12. Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas. Cancer Res. 2010 Feb 15; 70(4):1334-43.
    View in: PubMed
    Score: 0.052
  13. Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma. Clin Cancer Res. 2010 Feb 01; 16(3):848-56.
    View in: PubMed
    Score: 0.052
  14. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor. Int J Cancer. 2008 Aug 15; 123(4):831-7.
    View in: PubMed
    Score: 0.047
  15. Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma. Mol Cancer Ther. 2008 Jul; 7(7):1807-16.
    View in: PubMed
    Score: 0.046
  16. Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels. Mol Cancer Res. 2008 Jun; 6(6):929-36.
    View in: PubMed
    Score: 0.046
  17. VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature. Angiogenesis. 2008; 11(3):257-67.
    View in: PubMed
    Score: 0.045
  18. VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells. J Exp Ther Oncol. 2008; 7(2):89-97.
    View in: PubMed
    Score: 0.045
  19. VEGF(165), but not VEGF(189), stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo. Mol Cancer Res. 2007 Nov; 5(11):1125-32.
    View in: PubMed
    Score: 0.044
  20. Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. Cancer. 2006 Mar 15; 106(6):1382-8.
    View in: PubMed
    Score: 0.039
  21. Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma. Cancer. 2005 Oct 15; 104(8):1713-20.
    View in: PubMed
    Score: 0.038
  22. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases. Int J Cancer. 2005 Sep 01; 116(3):458-63.
    View in: PubMed
    Score: 0.038
  23. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Clin Cancer Res. 2005 Apr 01; 11(7):2662-9.
    View in: PubMed
    Score: 0.037
  24. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells. Clin Cancer Res. 2004 Dec 01; 10(23):8114-9.
    View in: PubMed
    Score: 0.036
  25. Association of alphavbeta3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells. Clin Exp Metastasis. 2004; 21(8):747-53.
    View in: PubMed
    Score: 0.034
  26. Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases. Clin Cancer Res. 2003 Aug 15; 9(9):3462-8.
    View in: PubMed
    Score: 0.033
  27. Nude mouse lung metastases models of osteosarcoma and Ewing's sarcoma for evaluating new therapeutic strategies. Methods Mol Med. 2003; 74:495-505.
    View in: PubMed
    Score: 0.032
  28. Vasculogenesis Plays a Role in the Growth of Ewing's Sarcoma in Vivo. Clin Cancer Res. 2002 Nov; 8(11):3622-7.
    View in: PubMed
    Score: 0.031
  29. Fas expression inversely correlates with metastatic potential in osteosarcoma cells. Oncol Rep. 2002 Jul-Aug; 9(4):823-7.
    View in: PubMed
    Score: 0.031
  30. Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16. Cancer Gene Ther. 2002 May; 9(5):407-13.
    View in: PubMed
    Score: 0.030
  31. Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector. Cancer Gene Ther. 2002 Mar; 9(3):260-6.
    View in: PubMed
    Score: 0.030
  32. Eradication of osteosarcoma lung metastasis using intranasal gemcitabine. Anticancer Drugs. 2002 Feb; 13(2):155-61.
    View in: PubMed
    Score: 0.030
  33. Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases. Clin Cancer Res. 2000 Sep; 6(9):3713-8.
    View in: PubMed
    Score: 0.027
  34. Vascular modulation through exercise improves chemotherapy efficacy in Ewing sarcoma. Pediatr Blood Cancer. 2019 09; 66(9):e27835.
    View in: PubMed
    Score: 0.025
  35. A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies. Clin Exp Metastasis. 1999; 17(6):501-6.
    View in: PubMed
    Score: 0.024
  36. Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity. J Pediatr Hematol Oncol. 2018 04; 40(3):208-215.
    View in: PubMed
    Score: 0.023
  37. BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation. Proc Natl Acad Sci U S A. 2017 07 25; 114(30):8065-8070.
    View in: PubMed
    Score: 0.022
  38. Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy. Cancer. 2010 Aug 15; 116(16):3892-902.
    View in: PubMed
    Score: 0.013
  39. Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs. Int J Cancer. 2009 Dec 01; 125(11):2586-94.
    View in: PubMed
    Score: 0.013
  40. Inhibiting platelet-derived growth factor beta reduces Ewing's sarcoma growth and metastasis in a novel orthotopic human xenograft model. In Vivo. 2009 Nov-Dec; 23(6):903-9.
    View in: PubMed
    Score: 0.013
  41. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. Br J Cancer. 2008 Apr 08; 98(7):1250-7.
    View in: PubMed
    Score: 0.011
  42. Intravenous administration of the conditionally replicative adenovirus Ad5-Delta24RGD induces regression of osteosarcoma lung metastases. Mol Cancer. 2008 Jan 23; 7:9.
    View in: PubMed
    Score: 0.011
  43. EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins. Cancer Res. 2007 Jul 15; 67(14):6675-84.
    View in: PubMed
    Score: 0.011
  44. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes. Cancer Gene Ther. 2001 Sep; 8(9):619-27.
    View in: PubMed
    Score: 0.007
  45. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. Clin Cancer Res. 2000 Jul; 6(7):2876-80.
    View in: PubMed
    Score: 0.007
  46. Anti-cancer activity of 9-nitrocamptothecin liposome aerosol in mice. Trans Am Clin Climatol Assoc. 2000; 111:135-45.
    View in: PubMed
    Score: 0.006
  47. 9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice. Ann N Y Acad Sci. 2000; 922:151-63.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.